Aceto Corp. Company Profile (NASDAQ:ACET)

About Aceto Corp.

Aceto Corp. logoAceto Corporation (Aceto) is engaged in marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment has two product groups: Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products. The Company has operations in China, Germany, France, the Netherlands, Singapore, India, Hong Kong, Philippines, the United Kingdom and the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Chemicals - Major Diversified
  • Sub-Industry: Trading Companies & Distributors
  • Exchange: NASDAQ
  • Symbol: ACET
  • CUSIP: 00444610
Key Metrics:
  • Previous Close: $18.54
  • 50 Day Moving Average: $19.04
  • 200 Day Moving Average: $22.06
  • 52-Week Range: $18.13 - $32.20
  • Trailing P/E Ratio: 15.71
  • Foreward P/E Ratio: 11.96
  • P/E Growth: 0.63
  • Market Cap: $549.67M
  • Outstanding Shares: 29,648,000
  • Beta: 1.5
  • Net Margins: 6.22%
  • Return on Equity: 15.39%
  • Return on Assets: 8.46%
  • Debt-to-Equity Ratio: 0.39%
  • Current Ratio: 3.57%
  • Quick Ratio: 2.57%
Additional Links:
Companies Related to Aceto Corp.:

Analyst Ratings

Consensus Ratings for Aceto Corp. (NASDAQ:ACET) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $30.00 (61.81% upside)

Analysts' Ratings History for Aceto Corp. (NASDAQ:ACET)
DateFirmActionRatingPrice TargetDetails
8/29/2016Craig HallumReiterated RatingBuyView Rating Details
3/30/2016First AnalysisInitiated CoverageOverweight$30.00View Rating Details
12/29/2014Singular ResearchBoost Price TargetBuy$24.00 -> $27.00View Rating Details
(Data available from 10/28/2014 forward)


Earnings History for Aceto Corp. (NASDAQ:ACET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2016ListenView Earnings Details
8/25/2016Q416$0.39$0.35$146.71 million$135.40 millionViewListenView Earnings Details
5/5/2016Q3$0.39$0.42$150.07 million$157.90 millionViewListenView Earnings Details
2/4/2016Q2$0.30$0.36$132.71 million$131.70 millionViewListenView Earnings Details
11/5/2015Q116$0.34$0.37$139.89 million$133.50 millionViewListenView Earnings Details
9/10/2015Q415$0.31$0.48$146.68 million$146.60 millionViewListenView Earnings Details
5/7/2015Q3$0.29$0.34$140.00 million$145.80 millionViewListenView Earnings Details
2/5/2015Q115$0.26$0.28$130.00 million$13.00 millionViewListenView Earnings Details
11/6/2014Q414$0.29$0.23$146.40 million$130.80 millionViewListenView Earnings Details
9/4/2014Q314$0.17$0.21$134.23 million$139.60 millionViewListenView Earnings Details
5/8/2014Q214$0.28$0.19$136.70 million$124.83 millionViewListenView Earnings Details
2/7/2014Q114$0.24$0.24$147.02 million$116.50 millionViewListenView Earnings Details
8/28/2013Q4 2013$0.20$0.19$113.10 million$123.10 millionViewListenView Earnings Details
5/9/2013Q3 2013$0.26$0.34$128.56 million$150.90 millionViewListenView Earnings Details
11/8/2012Q113$0.19$0.18$110.85 million$111.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aceto Corp. (NASDAQ:ACET)
Current Year EPS Consensus Estimate: $1.46 EPS
Next Year EPS Consensus Estimate: $1.55 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.35$0.40$0.37
Q2 20162$0.39$0.42$0.41
Q3 20161$0.39$0.39$0.39
Q4 20162$0.36$0.37$0.37
Q1 20172$0.29$0.29$0.29
Q2 20172$0.33$0.34$0.34
Q3 20172$0.36$0.47$0.42
Q4 20172$0.37$0.45$0.41
(Data provided by Zacks Investment Research)


Current Dividend Information for Aceto Corp. (NASDAQ:ACET)
Annual Dividend:$0.26
Dividend Yield:1.40%
Payout Ratio:22.03% (Based on Trailing 12 Months of Earnings)
17.81% (Based on Current Year Consensus EPS Estimate)
16.77% (Based on Next Year Consensus EPS Estimate)

Dividend History for Aceto Corp. (NASDAQ:ACET)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Aceto Corp. (NASDAQ:ACET)
Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 85.50%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/8/2016Salvatore J Sr Guccione SrInsiderSell260$19.64$5,106.40View SEC Filing  
9/7/2016Charles John AlaimoInsiderSell25$19.43$485.75View SEC Filing  
9/6/2016Albert L EilenderChairmanSell12,936$19.92$257,685.12View SEC Filing  
9/6/2016Frank DebenedittisInsiderSell4,580$19.85$90,913.00View SEC Filing  
9/6/2016Satish SrinivasanCOOSell3,980$19.84$78,963.20View SEC Filing  
9/6/2016Steven RogersSVPSell2,167$20.04$43,426.68View SEC Filing  
9/2/2016Charles John AlaimoInsiderSell2,567$19.85$50,954.95View SEC Filing  
7/19/2016Satish SrinivasanCOOSell595$25.48$15,160.60View SEC Filing  
7/7/2016Frank DebenedittisVPSell3,275$23.34$76,438.50View SEC Filing  
7/6/2016Albert L EilenderChairmanSell7,690$22.53$173,255.70View SEC Filing  
7/6/2016Charles John AlaimoSVPSell3,639$22.41$81,549.99View SEC Filing  
7/6/2016Douglas A RothCFOSell6,770$22.72$153,814.40View SEC Filing  
7/6/2016Salvatore J Sr Guccione SrCEOSell10,945$23.25$254,471.25View SEC Filing  
7/6/2016Satish SrinivasanCOOSell3,250$22.80$74,100.00View SEC Filing  
7/6/2016Steven RogersVPSell3,275$22.50$73,687.50View SEC Filing  
6/7/2016Terry KippleyVPSell2,000$22.50$45,000.00View SEC Filing  
6/7/2016William N BrittonDirectorSell4,200$23.12$97,104.00View SEC Filing  
6/6/2016Frank DebenedittisVPSell6,810$22.63$154,110.30View SEC Filing  
6/6/2016Satish SrinivasanCOOSell3,497$22.69$79,346.93View SEC Filing  
5/31/2016Albert L EilenderChairmanSell9,881$22.21$219,457.01View SEC Filing  
5/26/2016Douglas A RothCFOSell7,000$22.16$155,120.00View SEC Filing  
3/10/2016Raymond BartoneSVPSell3,000$22.40$67,200.00View SEC Filing  
3/8/2016Hans C NoetzliDirectorSell6,500$22.91$148,915.00View SEC Filing  
3/2/2016Frank DebenedittisVPSell3,000$21.98$65,940.00View SEC Filing  
3/1/2016Steven RogersVPSell2,100$21.82$45,822.00View SEC Filing  
2/25/2016Albert L EilenderChairmanSell9,281$21.79$202,232.99View SEC Filing  
2/23/2016Charles John AlaimoSVPSell4,750$21.91$104,072.50View SEC Filing  
2/23/2016Douglas A RothCFOSell17,000$21.52$365,840.00View SEC Filing  
12/9/2015Satish SrinivasanCOOSell3,000$27.02$81,060.00View SEC Filing  
12/9/2015Terry KippleyVPSell1,550$27.06$41,943.00View SEC Filing  
12/8/2015Nicolas I ShackleySVPSell3,000$26.70$80,100.00View SEC Filing  
12/1/2015Charles John AlaimoSVPSell3,000$28.22$84,660.00View SEC Filing  
11/25/2015Hans C. NoetzliDirectorSell3,000$27.52$82,560.00View SEC Filing  
11/24/2015Steven RogersVPSell3,000$27.56$82,680.00View SEC Filing  
10/15/2015Albert L. EilenderChairmanSell8,155$28.90$235,679.50View SEC Filing  
9/10/2015Charles John AlaimoSVPSell1,620$22.14$35,866.80View SEC Filing  
9/10/2015Douglas A. RothCFOSell6,250$22.14$138,375.00View SEC Filing  
9/10/2015Frank DebenedittisVPSell2,553$22.14$56,523.42View SEC Filing  
9/10/2015Salvatore J. Sr Guccione, Sr.CEOSell9,386$22.14$207,806.04View SEC Filing  
7/2/2015Albert L EilenderChairmanSell10,938$24.20$264,699.60View SEC Filing  
7/2/2015Charles John AlaimoSVPSell2,998$24.19$72,521.62View SEC Filing  
7/2/2015Douglas A RothCFOSell5,748$24.19$139,044.12View SEC Filing  
7/2/2015Frank DebenedittisVPSell2,629$24.19$63,595.51View SEC Filing  
7/2/2015Salvatore J Sr Guccione SrCEOSell9,114$24.19$220,467.66View SEC Filing  
7/2/2015Satish SrinivasanCOOSell1,921$24.19$46,468.99View SEC Filing  
6/8/2015Raymond BartoneSVPSell5,000$24.44$122,200.00View SEC Filing  
6/3/2015Frank DebenedittisVPSell4,000$24.41$97,640.00View SEC Filing  
5/27/2015Charles John AlaimoSVPSell2,000$23.19$46,380.00View SEC Filing  
5/12/2015William N BrittonDirectorSell13,000$21.31$277,030.00View SEC Filing  
3/4/2015Douglas A RothCFOSell5,000$20.99$104,950.00View SEC Filing  
3/4/2015Natasha GiordanoDirectorSell2,164$20.92$45,270.88View SEC Filing  
2/12/2015Douglas A RothCFOSell6,000$19.91$119,460.00View SEC Filing  
2/10/2015Charles John AlaimoSVPSell2,000$20.15$40,300.00View SEC Filing  
12/9/2014Frank DebenedittisVPSell3,000$21.25$63,750.00View SEC Filing  
12/5/2014Douglas A RothCFOSell7,000$22.07$154,490.00View SEC Filing  
12/3/2014Terry KippleyVPSell1,950$21.35$41,632.50View SEC Filing  
12/2/2014Terry KippleyVPSell1,797$21.45$38,545.65View SEC Filing  
12/1/2014Satish SrinivasanCOOSell1,430$21.00$30,030.00View SEC Filing  
11/11/2014Charles John AlaimoSVPSell2,250$21.22$47,745.00View SEC Filing  
9/9/2014Douglas A RothCFOSell6,000$21.57$129,420.00View SEC Filing  
9/9/2014Natasha GiordanoDirectorSell1,453$21.94$31,878.82View SEC Filing  
9/9/2014Raymond BartoneSVPSell3,000$21.49$64,470.00View SEC Filing  
9/9/2014Steven RogersVPSell8,335$21.50$179,202.50View SEC Filing  
9/2/2014Albert L EilenderChairmanSell7,144$19.14$136,736.16View SEC Filing  
8/29/2014Hans C NoetzliDirectorSell2,000$18.85$37,700.00View SEC Filing  
8/15/2014Hans C NoetzliDirectorSell2,000$18.63$37,260.00View SEC Filing  
8/4/2014Albert L EilenderChairmanSell4,195$16.71$70,098.45View SEC Filing  
8/1/2014Hans C NoetzliDirectorSell2,000$16.67$33,340.00View SEC Filing  
7/25/2014Albert L EilenderChairmanSell2,450$17.63$43,193.50View SEC Filing  
7/3/2014Hans C NoetzliDirectorSell2,000$17.86$35,720.00View SEC Filing  
7/2/2014Albert L EilenderChairmanSell1,750$18.05$31,587.50View SEC Filing  
6/6/2014Charles John AlaimoSVPSell2,000$17.51$35,020.00View SEC Filing  
6/6/2014Natasha GiordanoDirectorSell1,160$17.28$20,044.80View SEC Filing  
6/6/2014Steven RogersVPSell2,333$17.58$41,014.14View SEC Filing  
6/4/2014Frank DebenedittisVPSell30,000$17.09$512,700.00View SEC Filing  
6/4/2014Nicolas I ShackleyInsiderSell1,000$17.29$17,290.00View SEC Filing  
6/2/2014Douglas A RothCFOSell6,500$17.10$111,150.00View SEC Filing  
6/2/2014Natasha GiordanoDirectorSell1,149$17.43$20,027.07View SEC Filing  
5/23/2014Natasha GiordanoDirectorSell1,128$17.91$20,202.48View SEC Filing  
5/21/2014Natasha GiordanoDirectorSell1,110$17.81$19,769.10View SEC Filing  
3/10/2014Terry KippleyVPSell3,817$19.17$73,171.89View SEC Filing  
2/14/2014Roger Weaving, Jr.SVPSell6,000$18.96$113,760.00View SEC Filing  
11/12/2013Roger Weaving, Jr.SVPSell14,605$19.03$277,933.15View SEC Filing  
9/6/2013Raymond BartoneSVPSell19,000$14.84$281,960.00View SEC Filing  
6/7/2013Roger Weaving JrVPSell4,420$13.02$57,548.40View SEC Filing  
6/6/2013Guillaume Saint-ClairVPSell15,332$13.01$199,469.32View SEC Filing  
6/4/2013Douglas A RothCFOSell30,000$13.31$399,300.00View SEC Filing  
6/4/2013Eis Jan VanDirectorSell9,000$13.39$120,510.00View SEC Filing  
5/24/2013Ronald GoldCOOSell25,000$11.71$292,750.00View SEC Filing  
5/22/2013Frank DebenedittisVPSell8,300$11.86$98,438.00View SEC Filing  
5/21/2013Frank DebenedittisVPSell7,867$12.00$94,404.00View SEC Filing  
5/17/2013Douglas A RothCFOSell20,200$11.31$228,462.00View SEC Filing  
5/17/2013Guillaume Saint-ClairVPSell2,250$11.15$25,087.50View SEC Filing  
5/15/2013Ronald GoldCOOSell55,000$11.23$617,650.00View SEC Filing  
5/14/2013David B RosenVPSell40,000$11.05$442,000.00View SEC Filing  
5/14/2013Roger Weaving JrSVPSell5,600$11.09$62,104.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Aceto Corp. (NASDAQ:ACET)
DateHeadline logoACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News Release and Conference Call (NASDAQ:ACET) - October 21 at 8:19 PM logoETF’s with exposure to Aceto Corp. : October 18, 2016 (NASDAQ:ACET) - October 18 at 3:17 PM
News IconBenzocaine Market to 2021: Overview, Opportunities, In-Depth Analysis and Forecasts (NASDAQ:ACET) - October 13 at 3:16 PM
News IconVerdezyne, Aceto ink renewable chemicals distribution pact (NASDAQ:ACET) - October 10 at 8:03 AM
News IconVerdezyne signs distribution agreement with Aceto (NASDAQ:ACET) - October 8 at 8:05 AM logoNew Strong Sell Stocks for October 7th (NASDAQ:ACET) - October 7 at 3:17 PM
News IconVerdezyne Signs Distribution Agreement With Aceto Corporation To Power Regional Sales Of Verdezyne’s BIOLON®DDDA (NASDAQ:ACET) - October 6 at 3:15 PM
News IconVerdezyne In Chemical Distribution Deal (NASDAQ:ACET) - October 5 at 3:15 PM logoBRIEF-Verdezyne signs distribution agreement with Aceto Corp (NASDAQ:ACET) - October 5 at 3:15 PM logoVerdezyne Signs Distribution Agreement With Aceto Corporation (NASDAQ:ACET) - October 5 at 3:15 PM logoETF’s with exposure to Aceto Corp. : October 5, 2016 (NASDAQ:ACET) - October 5 at 3:15 PM logoAceto Corp. :ACET-US: Earnings Analysis: Q4, 2016 By the Numbers : October 4, 2016 (NASDAQ:ACET) - October 4 at 3:17 PM
News IconGlucuronolactone Market Is Expected To Reach USD 436.5 Million By 2024 : Radiant Insights,Inc (NASDAQ:ACET) - October 1 at 8:24 AM logoMoving Average Crossover Alert: Aceto (ACET) (NASDAQ:ACET) - September 27 at 3:15 PM logoGlucuronolactone Market Analysis By End-Use And Segment Forecasts To 2024 (NASDAQ:ACET) - September 23 at 3:31 PM logoACETO Subsidiary, Rising Pharmaceuticals, to Launch Fluocinolone Acetonide OTIC Oil, 0.01% (NASDAQ:ACET) - September 16 at 11:58 AM
News IconBasalt ballot boils down to dueling visions for Pan and Fork site (NASDAQ:ACET) - September 12 at 8:04 AM
News IconPRESIDENT AND CEO of Aceto Corporation (NASDAQ:ACET), Guccione Salvatore J Sr, sells 260 shares worth $5,106 (NASDAQ:ACET) - September 9 at 8:05 AM logoACETO Corp (ACET) Adds New Board Member (NASDAQ:ACET) - September 7 at 8:25 PM
News IconSENIOR VICE PRESIDENT of Aceto Corporation (NASDAQ:ACET), Shackley Nicolas I, sells 5,048 shares worth $100,203 (NASDAQ:ACET) - September 7 at 8:25 PM logoACETO Appoints William C. Kennally, III to the Board of Directors (NASDAQ:ACET) - September 6 at 8:25 PM logoACETO to Present at the Morgan Stanley 2016 Global Healthcare Conference (NASDAQ:ACET) - September 6 at 3:15 PM logoWhat Makes Aceto (ACET) a Strong Sell? (NASDAQ:ACET) - September 1 at 11:44 AM logoACETO CORP Financials (NASDAQ:ACET) - August 31 at 3:18 PM logoAceto Corp. (ACET) Sank To A 3-Month Low After Q4 Profit Fell (NASDAQ:ACET) - August 29 at 3:35 PM logoAceto Corp. :ACET-US: Earnings Analysis: 2016 By the Numbers : August 29, 2016 (NASDAQ:ACET) - August 29 at 3:35 PM logoETF’s with exposure to Aceto Corp. : August 29, 2016 (NASDAQ:ACET) - August 29 at 3:35 PM logoThese 2 Stocks Just Raised Their Dividends (NASDAQ:ACET) - August 29 at 9:13 AM logoWhy Shares of Aceto Corporation Plunged 23% Today (NASDAQ:ACET) - August 26 at 3:58 PM logoACETO : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) (NASDAQ:ACET) - August 26 at 3:16 PM logoACETO's (ACET) CEO Sal Guccione on Q4 2016 Results - Earnings Call Transcript (NASDAQ:ACET) - August 26 at 3:16 PM logoACETO Corp (ACET) Misses Q4 EPS by 4c (NASDAQ:ACET) - August 26 at 3:16 PM logoAceto (ACET) Stock Tumbles on Q4 Miss (NASDAQ:ACET) - August 26 at 3:16 PM logoACETO Board of Directors Increases Quarterly Cash Dividend by 8.3% (NASDAQ:ACET) - August 26 at 11:24 AM logoAceto Corp. (ACET) Has Fallen To A 2-Month Low After Drop In Q4 Earnings (NASDAQ:ACET) - August 26 at 11:24 AM
News IconAceto Corp. reports drop in profit, sales (NASDAQ:ACET) - August 26 at 11:24 AM logoACETO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:ACET) - August 26 at 11:24 AM logoBRIEF-Aceto's board increases qtrly dividend by 8.3 pct to $0.065/share (NASDAQ:ACET) - August 25 at 8:44 PM logoAceto Corp Earnings Call (Q4 2016) (NASDAQ:ACET) - August 25 at 8:44 PM logoAceto : posts 4Q profit (NASDAQ:ACET) - August 25 at 8:44 PM logoAceto Corp. Announces 27% Decline In Q4 Earnings (NASDAQ:ACET) - August 25 at 8:44 PM logoAceto posts 4Q profit (NASDAQ:ACET) - August 25 at 8:44 PM logoACETO Reports Fiscal 2016 Fourth Quarter and Record Full Year Results (NASDAQ:ACET) - August 25 at 8:44 PM logoAceto Corporation declares $0.065 dividend (NASDAQ:ACET) - August 25 at 3:50 PM logoQ4 2016 Aceto Corp Earnings Release - After Market Close (NASDAQ:ACET) - August 25 at 8:04 AM
News IconGlucuronolactone Market Volume Forecast and Value Chain Analysis 2015-2025 (NASDAQ:ACET) - August 24 at 11:36 AM logo11:18 am Aceto launches Fluocinolone Acetonide Body Oil 0.01%, a generic version of Derma-Smoothe/FS body oil & Fluocinolone Acetonide Scalp Oil 0.01%, a generic version of Derma-Smoothe/FS scalp oil (NASDAQ:ACET) - August 23 at 3:16 PM logoACETO Subsidiary, Rising Pharmaceuticals, to launch Fluocinolone Acetonide Body Oil, 0.01%, and Fluocinolone Acetonide Scalp Oil, 0.01% (NASDAQ:ACET) - August 23 at 3:16 PM logoACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results News Release and Conference Call (NASDAQ:ACET) - August 12 at 11:51 AM logoETF’s with exposure to Aceto Corp. : July 26, 2016 (NASDAQ:ACET) - July 26 at 12:38 PM


Aceto Corp. (NASDAQ:ACET) Chart for Friday, October, 28, 2016

Last Updated on 10/28/2016 by Staff